Hebert Peter
SEC-identified person · CIK 1683771 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Eikon Therapeutics, Inc. EIKN | Officer | filed 2026 - 2026 |
| Matterport, Inc./DE MTTR | Director | filed 2021 - 2025 |
| Interprivate Acquisition Corp. IPVU | Officer | filed 2021 - 2022 |
| Science 37 Holdings, Inc. SNCE | Officer | filed 2021 - 2022 |
| Recursion Pharmaceuticals, INC. RXRX | Officer | filed 2021 - 2021 |
| TS Innovation Acquisitions Corp. TSIA | Officer | filed 2021 - 2021 |
| Lux Health Tech Acquisition Corp. LUXA | Director | filed 2020 - 2020 |
| Everspin Technologies INC. MRAM | Director | filed 2016 - 2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.